Evidence map›Paper›PMID 26214128›Full record

ArticleNature methods2015

A microfluidic device for epigenomic profiling using 100 cells.

Zhenning Cao, Changya Chen, Bing He, Kai Tan, Chang Lu

Abstract read
In one paragraph

Article in Nature methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Microfluidic low-input profiling reveals lncRNA roles in disease.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cell-type-specific epigenomic variations associated withNAR genomics and bioinformatics · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenning CaoDepartment of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, Virginia, USA.
Changya ChenInterdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, Iowa, USA.
Bing HeInterdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, Iowa, USA.
Kai TanInterdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, Iowa, USA.
Chang LuDepartment of Chemical Engineering, Virginia Tech, Blacksburg, Virginia, USA.

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
EPIGENETIC REGULATION OF STEM CELL FATE CHOICER01HG006130 · NHGRI · UNIVERSITY OF IOWA · PI TAN, KAI · 2012 to 2016
$1.7M
Probing dynamics in protein-DNA interactions during disease development using sinR01EB017235 · NIBIB · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LU, CHANG · 2014 to 2017
$1.3M
Computational Methods for Unraveling Combinatorial Gene RegulationR01GM108716 · NIGMS · UNIVERSITY OF IOWA · PI TAN, KAI · 2014 to 2017
$1.2M
A TOOLKIT FOR IDENTIFYING CAUSAL VARIANTS IN TRANSCRIPTIONAL ENHANCERSR01GM104369 · NIGMS · UNIVERSITY OF IOWA · PI TAN, KAI · 2014 to 2017
$1.2M
Sensitive and integrated microfluidic ChIP assays for studying transcriptional reR21CA174577 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LU, CHANG · 2013 to 2015
$697k
Ultrasensitive device for epigenomic profiling of stem cell differentiationR21EB017855 · NIBIB · UNIVERSITY OF IOWA · PI LU, CHANG, TAN, KAI · 2014 to 2015
$431k
NCI NIH HHS CA174577NCI NIH HHS R21 CA174577NHGRI NIH HHS HG006130NHGRI NIH HHS R01 HG006130NIBIB NIH HHS EB017235NIBIB NIH HHS EB017855NIBIB NIH HHS R01 EB017235NIBIB NIH HHS R21 EB017855NIEHS NIH HHS P30 ES005605NIGMS NIH HHS GM104369NIGMS NIH HHS R01 GM104369NIGMS NIH HHS R01 GM108716
6 · The paper itself

Abstract

The sensitivity of chromatin immunoprecipitation (ChIP) assays poses a major obstacle for epigenomic studies of low-abundance cells. Here we present a microfluidics-based ChIP-seq protocol using as few as 100 cells via drastically improved collection of high-quality ChIP-enriched DNA. Using this technology, we uncovered many new enhancers and super enhancers in hematopoietic stem and progenitor cells from mouse fetal liver, suggesting that enhancer activity is highly dynamic during early hematopoiesis.

Indexed as

Lab-On-A-Chip DevicesAcetylationAnimalsChromatin ImmunoprecipitationEnhancer Elements, GeneticEpigenomicsEquipment DesignFemaleHematopoiesisHematopoietic Stem CellsHistonesHumansLiverMaleManufacturing IndustryMice, Inbred C57BLHistones

Identifiers

PMID26214128
PMCPMC4589469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.